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One hundred years ago, John Brian Christopherson (1868–1955) discovered that antimony potassium tartrate was an effective treatment against schistosomiasis. Antimony had been 
previously used against visceral leishmaniasis, Trypanosoma brucei gambiense, and yaws. The 
ancient Egyptians used antimony paste as mascara. In the Middle Ages, it was used as a laxative, 
which, after swallowing and retrieval, could be reused. Alchemists used it to harden lead.
Its name might have been derived from the Egyptian word for the metal sdm, from which the 
Greek stimmi, then the Latin stibium, then the French antimoine were derived. A more interesting, 
but unlikely, origin is that the French antimoine translates as monk’s killer, referring to its 
toxicity to religious alchemists. Antimony potassium tartrate remained the treatment of choice for 
schistosomiasis until the development of praziquantel in the 1980s.
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 A) Antimony, unknown author, http://images-of-elements.com/, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=9084452;  
B) Antimony potassium tartrate trihydrate, Chargelot, own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=47342907;  
C) Bone marrow aspiration: Leishmaniasis (Leishmania sp.) in liver transplant recipient, Paulo Henrique Orlandi Mourao, 2009,  
https://en.wikipedia.org/wiki/Leishmaniasis#/media/File:Leishmania_2009-04-14_smear.JPG;
that the correct diagnosis for the 65-year-old woman in the 
study by Polley et al. (1) was visceral leishmaniasis caused 
by infection with L. martiniquensis.
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